Dose-dense Temozolomide: Is It Still Promising?
Glioblastoma (GBM) has proven to be incurable despite recent progress on its standard of care using temozolomide (TMZ) as the main trunk of initial therapy for newly diagnosed GBM. One of the main reasons accounting for the dismal prognosis is attributed to lack of active therapeutic regimens at rec...
| Main Author: | |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
The Japan Neurosurgical Society
2015
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4533399/ |